Flagship Biosciences works with a large number of biotech companies, from a start-up working virtually to companies who have emerged successfully from their early days and have compounds in the pipeline or drugs on the market. There are so many areas of expertise required for a biotech company to move a product to market, including pathology. The largest pharmaceutical companies employ up to 50 board-certified veterinary pathologists, a small biotech is unlikely to have a single pathologist.
Flagship brings over 60 years of combined drug development pathology expertise to help you with your compound, plus cutting edge image analysis technology for making quantitative, reproducible measurements in tissue. Your investors and the regulatory agencies demand quantitative efficacy results, we deliver data you can depend on.
All of our services require no capital investment, so biotech companies can better manage their cash resources, getting results faster.
Examples of discovery pathology services that are common to biotech companies include slide scanning, cloud hosting, xenograft analysis, angiogenesis measurements, beta cell mass changes, and many other areas. Please explore our disease areas for more examples, and contact our pathologists to discuss your project needs.
